MAXALT - 16590-461-18 - (RIZATRIPTAN BENZOATE)

Alphabetical Index


Drug Information of MAXALT

Product NDC: 16590-461
Proprietary Name: MAXALT
Non Proprietary Name: RIZATRIPTAN BENZOATE
Active Ingredient(s): 10    mg/1 & nbsp;   RIZATRIPTAN BENZOATE
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of MAXALT

Product NDC: 16590-461
Labeler Name: STAT RX USA LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020864
Marketing Category: NDA
Start Marketing Date: 19980629

Package Information of MAXALT

Package NDC: 16590-461-18
Package Description: 18 POUCH in 1 CARTON (16590-461-18) > 1 TABLET in 1 POUCH

NDC Information of MAXALT

NDC Code 16590-461-18
Proprietary Name MAXALT
Package Description 18 POUCH in 1 CARTON (16590-461-18) > 1 TABLET in 1 POUCH
Product NDC 16590-461
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name RIZATRIPTAN BENZOATE
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 19980629
Marketing Category Name NDA
Labeler Name STAT RX USA LLC
Substance Name RIZATRIPTAN BENZOATE
Strength Number 10
Strength Unit mg/1
Pharmaceutical Classes Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Complete Information of MAXALT


General Information